Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Yamada

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Biorxiv : the Preprint Server for Biology|June 9, 2023
Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy Ken Yamada, Vignesh Narayan Hariharan, Jillian Caiazzi, et al.
Journal of Medicinal Chemistry|August 4, 2017
Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension ModelsKen Yamada, Julian Levell, Taeyong Yoon, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS miceAlexandra Weiss, James W Gilbert, Iris Valeria Rivera Flores, et al.
ACS Chemical Biology|October 8, 2016
Discovery and Characterization of Allosteric WNK Kinase InhibitorsKen Yamada, Ji-Hu Zhang, Xiaoling Xie, et al.
Nucleic Acids Research|June 23, 2025
Systematic analysis of siRNA and mRNA features impacting fully chemically modified siRNA efficacySarah M Davis, Samuel Hildebrand, Hannah J MacMillan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 11, 2025
RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS miceAlexandra Weiss, James W Gilbert, Iris Valeria Rivera Flores, et al.
Nature Biotechnology|August 1, 2024
Enhancing siRNA efficacy in vivo with extended nucleic acid backbonesKen Yamada, Vignesh N Hariharan, Jillian Caiazzi, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Fully Modified SpyCas9 Guide RNAs Enable Robust Genome Editing In Cells and In VivoKim Anh Vu, Han Zhang, Nadia Amrani, et al.
Nucleic Acids Research|April 25, 2026
Divalent siRNA for prion diseaseJuliana E Gentile, Taylor L Corridon, Fiona E Serack, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Divalent siRNA for prion diseaseJuliana E Gentile, Taylor L Corridon, Fiona E Serack, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Biorxiv : the Preprint Server for Biology|June 9, 2023
Extended Nucleic Acid (exNA): A Novel, Biologically Compatible Backbone that Significantly Enhances Oligonucleotide Efficacy Ken Yamada, Vignesh Narayan Hariharan, Jillian Caiazzi, et al.
Journal of Medicinal Chemistry|August 4, 2017
Optimization of Allosteric With-No-Lysine (WNK) Kinase Inhibitors and Efficacy in Rodent Hypertension ModelsKen Yamada, Julian Levell, Taeyong Yoon, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS miceAlexandra Weiss, James W Gilbert, Iris Valeria Rivera Flores, et al.
ACS Chemical Biology|October 8, 2016
Discovery and Characterization of Allosteric WNK Kinase InhibitorsKen Yamada, Ji-Hu Zhang, Xiaoling Xie, et al.
Nucleic Acids Research|June 23, 2025
Systematic analysis of siRNA and mRNA features impacting fully chemically modified siRNA efficacySarah M Davis, Samuel Hildebrand, Hannah J MacMillan, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 11, 2025
RNAi-mediated silencing of SOD1 profoundly extends survival and functional outcomes in ALS miceAlexandra Weiss, James W Gilbert, Iris Valeria Rivera Flores, et al.
Nature Biotechnology|August 1, 2024
Enhancing siRNA efficacy in vivo with extended nucleic acid backbonesKen Yamada, Vignesh N Hariharan, Jillian Caiazzi, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
Fully Modified SpyCas9 Guide RNAs Enable Robust Genome Editing In Cells and In VivoKim Anh Vu, Han Zhang, Nadia Amrani, et al.
Nucleic Acids Research|April 25, 2026
Divalent siRNA for prion diseaseJuliana E Gentile, Taylor L Corridon, Fiona E Serack, et al.
Biorxiv : the Preprint Server for Biology|March 23, 2026
Divalent siRNA for prion diseaseJuliana E Gentile, Taylor L Corridon, Fiona E Serack, et al.
Pageof 6